REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Deak Pharma Bt. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: DEAK PHARMA Gyogyszer-Kiskereskedelmi Bt. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

Deak Pharma Bt. is based in Hungary. The head office is in Szeged. It operates in the Pharmacies and Drug Stores industry. It was first established on December 15, 1998. 4 (2024) employees currently work for Deak Pharma Bt.. From the latest financial highlights, Deak Pharma Bt. reported a net sales revenue increase of 1.11% in 2023. During that time, Deak Pharma Bt.’s total assets decreased by 10.46%. In 2023, Deak Pharma Bt.’s net profit margin decreased by 0.29%.

Headquarters
Tisza L. u. 92.
Szeged; Csongrad; Postal Code: 6725

Contact Details: Purchase the Deak Pharma Bt. report to view the information.

Basic Information
Total Employees:
Purchase the Deak Pharma Bt. report to view the information.
Outstanding Shares:
Purchase the Deak Pharma Bt. report to view the information.
Registered Capital:
Purchase the Deak Pharma Bt. report to view the information.
Financial Auditors:
Purchase the Deak Pharma Bt. report to view the information.
Incorporation Date:
December 15, 1998
Key Executives
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Csanad Pharma Kft.
Company Performance
Financial values in the chart are available after Deak Pharma Bt. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
1.11%▲
Total operating revenue
0.27%▲
Operating profit (EBIT)
5.16%▲
EBITDA
4.02%▲
Net Profit (Loss) for the Period
-13.09%▼
Total assets
-10.46%▼
Total equity
-38%▼
Operating Profit Margin (ROS)
0.08%▲
Net Profit Margin
-0.29%▼
Return on Equity (ROE)
-27.69%▼
Quick Ratio
-0.14%▼
Cash Ratio
-0.12%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo